Document Detail


A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.
MedLine Citation:
PMID:  11176943     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine if callosal atrophy and interhemispheric dysfunction can be detected in the early stages of relapsing-remitting multiple sclerosis (MS) and to evaluate their progression in relation to the disability and evolution of lesions seen on magnetic resonance imaging during a 5-year period. METHODS: We compared 30 patients who had clinically definite early-onset replasing-remitting MS and mild disability with control subjects. Regional and segmental callosal size and extent of white matter abnormalities on magnetic resonance imaging, as well as performance on tasks exploring interhemispheric transfer of motor, auditory, and sensory information were assessed. Patients with MS were evaluated at baseline and after 5 years. Physical disability was determined at both times using the Expanded Disability Status Scale score. RESULTS: Patients with MS were seen with significant callosal atrophy and functional impairment of interhemispheric transfer at baseline that worsened during the 5-year study. A significant correlation was found between the magnitude of disability and the severity of morphological and functional callosal involvement at baseline. This association persisted at year 5. Baseline clinical characteristics such as age and prestudy relapse rate were unrelated to callosal size or interhemispheric performance. However, the number of baseline T2-weighted lesions was correlated with callosal involvement and this relation persisted at year 5. CONCLUSION: Patients who had relapsing-remitting MS in the early stages of the disease and mild disability had significant callosal involvement that progressed over time. The relationship between disability, T2-weighted lesions load, and degree of morphological and functional callosal impairment confirm the potential value of using callosal dysfunction as a surrogate marker of disease progression in MS.
Authors:
J Pelletier; L Suchet; T Witjas; M Habib; C R Guttmann; G Salamon; O Lyon-Caen; A A Chérif
Related Documents :
9708823 - Histopathological characterization of magnetic resonance imaging-detectable brain white...
17727663 - Magnetic resonance imaging of the brain used to detect early post-partum activation of ...
1949143 - Schistosomal periportal fibrosis in zimbabwe: use of ultrasound in patients with oesoph...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of neurology     Volume:  58     ISSN:  0003-9942     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-02-22     Completed Date:  2001-03-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  105-11     Citation Subset:  AIM; IM    
Affiliation:
Department of Neurology, CHU Timone, F-13385 Marseilles 5, France. jpelletier@ap-hm.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Atrophy / pathology
Corpus Callosum / pathology*,  physiopathology*
Dichotic Listening Tests
Disability Evaluation
Disease Progression
Evoked Potentials, Auditory, Brain Stem / physiology
Female
Functional Laterality / physiology
Humans
Longitudinal Studies
Magnetic Resonance Imaging
Male
Multiple Sclerosis, Relapsing-Remitting / diagnosis*,  physiopathology*
Neuropsychological Tests
Severity of Illness Index

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Linear pontine trigeminal root lesions in multiple sclerosis: clinical and magnetic resonance imagin...
Next Document:  Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a lo...